Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management...

Stockhouse Apr 25 18:45 ET

Mydecine Innovations Group Receives Notice of Allowance From USPTO For MYCO-005 Compound

MT NewswiresDec 18, 2023 07:23 ET

Canadian Securities Exchange Reports October 2023 Performance Figures

newsfileNov 17, 2023 12:02 ET

Mydecine Innovations Group Provided Q4 2023 Business Update

MT NewswiresOct 26, 2023 07:48 ET

Mydecine Innovations Group Brief: Announced Admission to Trading on AQSE Growth Market in London, UK and First Day of Dealings

MT NewswiresOct 10, 2023 06:17 ET